Obstructive sleep apnoea and type 1 diabetes mellitus

Hiang Leng Tan, Feaz Babwah, Najeeb Waheed, Muhammad Imran Butt

Full Text:



Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328(17):1230-5. http://dx.doi.org/10.1056/NEJM199304293281704

Foster GD, Saunder MH, Millman R et al. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care 2009;32:1017-19. http://dx.doi.org/10.2337/dc08-1776

Borel AL, Benhamou PY, Baguet JP et al. High prevalence of obstructive sleep apnoea syndrome in a Type 1 diabetic adult population. Diabet Med 2010;27(11):1328-9. http://dx.doi.org/10.1111/j.1464-5491.2010.03096.x

Manin G, Pons A, Baltzinger P et al. Obstructive sleep apnoea in people with Type 1 diabetes: prevalence and association with micro- and macrovascular complications. Diabet Med 2015;32:90-6. http://dx.doi.org/10.1111/dme.12582

Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-53. http://dx.doi.org/10.1016/S0140-6736(05)74229-X

Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005;353:2034-41. http://dx.doi.org/10.1056/NEJMoa043104

Alert over misdiagnosis of Diabetes. March 2011. (Cited 17 June 2013). Available from URL: http://www.diabetes.co.uk

Molbak AG, Christau B, Marner B et al. Incidence of insulin-dependant diabetes mellitus in age groups over 30 years in Denmark. Diabet Med 1994;11(7):650-5. http://dx.doi.org/10.1111/j.1464-5491.1994. tb00327.x

Diabetes-related Autoantibodies. (Cited 17 June 2013). Available from URL: http://labtestsonline.org

Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med 2013;30:803-17. http://dx.doi.org/10.1111/dme.12159

Juneja R, Hirsch IB, Naik RG et al. Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes. Metabolism 2001;50:1008-13. http://dx.doi.org/10.1053/meta.2001.25654

Meyer L, Guerci B. Metformin and insulin in type 1 diabetes. Diabetes Care 2003;26(5):1655-6. http://dx.doi.org/10.2337/diacare.26.5.1655-a

Jacobsen IB, Henriksen JE, Beck-Nielsen H. The effect of metformin in overweight patients with type 1 diabetes and poor metabolic control. Basic Clin Pharmacol Toxicol 2009;105:145-9. http://dx.doi.org/10.1111/j.1742-7843.2009.00380.x

DOI: https://doi.org/10.15277/bjdvd.2015.020


  • There are currently no refbacks.

The Journal of the Association of British Clinical Diabetologists